SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-263647
Filing Date
2023-10-26
Accepted
2023-10-26 09:30:52
Documents
14
Period of Report
2023-10-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d550531d8k.htm   iXBRL 8-K 26233
2 EX-99.1 d550531dex991.htm EX-99.1 10575
6 GRAPHIC g550531g1026005603759.jpg GRAPHIC 3024
  Complete submission text file 0001193125-23-263647.txt   168093

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20231026.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20231026_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20231026_pre.xml EX-101.PRE 11253
8 EXTRACTED XBRL INSTANCE DOCUMENT d550531d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 231347727
SIC: 2834 Pharmaceutical Preparations